Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.


Journal

Cancer immunology, immunotherapy : CII
ISSN: 1432-0851
Titre abrégé: Cancer Immunol Immunother
Pays: Germany
ID NLM: 8605732

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 30 11 2019
medline: 30 11 2019
entrez: 29 11 2019
Statut: ppublish

Résumé

The original version of this article unfortunately included a mistake in Fig. 2b where the images of mice in the tumour control group (right), day 30 (bottom) should be removed as the wrong images (duplicate of day 17) were inserted by mistake. At this time point the tumour control mice were no longer alive and the images were replaced by black areas.

Identifiants

pubmed: 31776597
doi: 10.1007/s00262-019-02409-6
pii: 10.1007/s00262-019-02409-6
pmc: PMC6949204
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-161

Commentaires et corrections

Type : ErratumFor

Auteurs

Nadia Mensali (N)

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.

Marit Renée Myhre (MR)

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.

Pierre Dillard (P)

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.

Sylvie Pollmann (S)

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.

Gustav Gaudernack (G)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.
Faculty of Medicine, University of Oslo, 0316, Oslo, Norway.

Gunnar Kvalheim (G)

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.

Sébastien Wälchli (S)

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway. sebastw@rr-research.no.

Else Marit Inderberg (EM)

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway. elsmar@rr-research.no.

Classifications MeSH